🇺🇸 ACEI/ARB in United States
2 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 21 April 2025 – 21 April 2026
- Total reports: 2
Most-reported reactions
- Acute Kidney Injury — 1 report (50%)
- Contraindicated Product Prescribed — 1 report (50%)
Other Cardiovascular approved in United States
Frequently asked questions
Is ACEI/ARB approved in United States?
ACEI/ARB does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for ACEI/ARB in United States?
Capital Institute of Pediatrics, China is the originator. The local marketing authorisation holder may differ — check the official source linked above.